EcoDrugPlus


Keyword(s):	Surfactants ; Human Metabolites
Molecule Category	Free-form

Keyword(s):

Surfactants ; Human Metabolites

Molecule Category

Free-form


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70


InChI Key	DOHZNHZHDHMXQB-UHFFFAOYSA-N
Smiles	N1(C)C(CC(C1)=O)c2cnccc2
InChI	InChI=1S/C10H12N2O/c1-12-7-9(13)5-10(12)8-3-2-4-11-6-8/h2-4,6,10H,5,7H2,1H3

InChI Key

DOHZNHZHDHMXQB-UHFFFAOYSA-N

Smiles

N1(C)C(CC(C1)=O)c2cnccc2

InChI

InChI=1S/C10H12N2O/c1-12-7-9(13)5-10(12)8-3-2-4-11-6-8/h2-4,6,10H,5,7H2,1H3

Property Name	Value
Molecular Formula	C10H12N2O1
Molecular Weight	176.09
AlogP	1.03
Hydrogen Bond Acceptor	3.0
Hydrogen Bond Donor	0.0
Number of Rotational Bond	1.0
Polar Surface Area	33.2
Molecular species	None
Aromatic Rings	1.0
Heavy Atoms	13.0

Property Name

Value

Molecular Formula

C10H12N2O1

Molecular Weight

176.09

AlogP

1.03

Hydrogen Bond Acceptor

3.0

Hydrogen Bond Donor

0.0

Number of Rotational Bond

1.0

Polar Surface Area

33.2

Molecular species

None

Aromatic Rings

1.0

Heavy Atoms

13.0

Resources	Reference
NORMAN SUSDAT
PubChem	14286223
ChemSpider	60683481.0

Resources

Reference

NORMAN SUSDAT

PubChem

14286223

ChemSpider

60683481.0


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

1-METHYL-5-PYRIDIN-3-YLPYRROLIDIN-3-ONE (NICOTINE MET 4-176)

Structure

Physicochemical Descriptors

Cross References